MeSH D001145 - cardiac arrhythmias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006331:Heart diseases
0 Companies
0 Drugs
Success rate
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D001145:Â
Cardiac arrhythmias
D001146:Sinus arrhythmia
0 Companies
0 Drugs
Success rate
D001281:Atrial fibrillation
D001282:Atrial flutter
D001919:Bradycardia
D005117:Premature cardiac complexes
0 Companies
0 Drugs
Success rate
D006327:Heart block
D008133:Long qt syndrome
0 Companies
0 Drugs
Success rate
D011226:Pre-excitation syndromes
0 Companies
0 Drugs
Success rate
D013610:Tachycardia
0 Companies
0 Drugs
Success rate
D014693:Ventricular fibrillation
D017574:Parasystole
0 Companies
0 Drugs
Success rate
D053840:Brugada syndrome
0 Companies
0 Drugs
Success rate
D054141:Ventricular flutter
0 Companies
0 Drugs
Success rate
D056104:Commotio cordis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amiodarone | Amiodarone |  | 1998-11-30 |  |  |
| Disopyramide | Disopyramide |  | 1985-02-22 |  |  | |
| Dofetilide | Dofetilide |  | 2022-04-15 |  |  | |
| Lidocaine, Prilocaine | Emla |  | 1992-12-30 |  |  | |
| Lidocaine | Lidocaine |  | 2018-01-16 |  |  | |
| Mexiletine | Mexiletine |  | 1995-05-16 |  |  | |
| Procainamide | Procainamide |  | 1982-01-01 |  |  | |
| Quinidine | Quinidine |  | 1982-01-01 |  |  | |
| Sotalol | Sotalol |  | 2000-05-01 |  |  | |
| Novast Laboratories | Dofetilide | Dofetilide |  | 2019-12-27 |  |  |
| Mexiletine | Mexiletine |  | 2021-01-25 |  |  | |
| Padagis | Lidocaine, Prilocaine | Lidocaine Prilocaine |  | 2021-07-27 |  |  |
| Taro Pharmaceutical | Amiodarone | Amiodarone |  | 2001-03-30 |  |  |
| Lidocaine | Lidocaine |  | 1982-01-01 |  |  | |
| Lidocaine, Tetracaine | Pliaglis | 2031-01-14 | 2006-06-29 |  |  | |
| Glenmark Pharmaceuticals | Lidocaine | Lidocaine |  | 2016-09-09 |  |  |
| Propafenone | Propafenone |  | 2017-09-08 |  |  | |
| Mylan | Amiodarone | Amiodarone |  | 1999-02-24 |  |  |
| Disopyramide | Disopyramide |  | 1985-06-14 |  |  | |
| Lidocaine | Lidocaine |  | 2015-08-07 |  |  | |
| Propafenone | Propafenone |  | 2016-04-29 |  |  | |
| Rising Pharmaceuticals | Lidocaine | Lidocaine |  | 2010-09-27 |  |  |
| Sotalol | Sotalol |  | 2000-12-19 |  |  | |
| Disopyramide | Disopyramide |  | 1985-12-10 |  |  | |
| Propafenone | Propafenone |  | 2018-07-02 |  |  | |
| Quinidine | Quinidine |  | 1988-12-15 |  |  | |
| Mexiletine | Mexiletine |  | 2022-08-26 |  |  | |
| Perrigo | Quinidine | Quinidine |  | 1982-01-01 |  |  |
| GSK | Propafenone | Rythmol |  | 1989-11-27 |  |  |
| Roche | Ceftriaxone, Lidocaine | Rocephin |  | 1984-12-21 | $261.442 M | Y2021 |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
67%6/9
Phase 2
60%12/20
Phase 3
72%33/46
Approved: 18Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use